Preclinical Efficacy of the Auristatin-Based Antibody-Drug Conjugate BAY 1187982 for the Treatment of FGFR2-Positive Solid Tumors.
暂无分享，去创建一个
H. Huynh | A. Sommer | S. Hammer | K. Ziegelbauer | J. Schuhmacher | H. Apeler | Sabine Wittemer-Rump | Simone Greven | A. Harrenga | C. Schatz | H. Lerchen | B. Stelte-Ludwig | F. Dittmer | B. Kreft | C. Kopitz | R. Jautelat | C. Mahlert | C. Nising | R. Zierz | Frank Reetz | Manuela Braun | S. Wittemer-Rump | Christoph A Schatz